Coeptis Therapeutics Holdings, Inc. (COEP)
12.44
+0.34
(+2.81%)
USD |
NASDAQ |
Apr 14, 16:00
12.27
-0.17
(-1.37%)
After-Hours: 20:00
Coeptis Therapeutics Holdings EPS Diluted (Quarterly) : -0.2746 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.623M |
| Revenue (Quarterly) | 0.862M |
| Total Expenses (Quarterly) | 2.440M |
| Enterprise Value | 71.84M |
| Gross Profit Margin (Quarterly) | -14.56% |
| Profit Margin (Quarterly) | -188.3% |
| Earnings Yield | -22.51% |
| Normalized Earnings Yield | -24.38 |